Emerging therapies such as bezuclastinib and elenestinib show promise in improving disease control with potentially fewer toxicities. Other novel strategies, such as immune-based therapies, are under ...

The Ambifect version of the new trial drug builds on Akston's anti-cPD-L1 mAb, designed to target and block the cPD-L1 protein on cancer cells, which is currently in clinical trial for dogs with ...

Akston, the Biotech Built for Pets, in partnership with Purdue University and its College of Veterinary Medicine, announced today that it has initiated a clinical study to evaluate a first–in–class ...

Mast cell tumors are prevalent skin neoplasms observed in veterinary clinical practice, particularly affecting both dogs and cats. Over the years, rigorous ...

A: A mast cell tumor, or MCT, is the most common form of skin cancer in dogs. Mast cells are white blood cells designed to fight parasites and allergies. It's not clear why some of these immune cells ...

The most common treatment is surgical removal of the MCT, which is often curative, especially for low-grade tumors that are ...

Background: Cold air and air pollution are known triggers to induce symptoms in exercise-induced bronchoconstriction (EIB). Mast cells are hypothesized to be a key player in the pathogenesis of EIB.

The survey also found that as the number of lumps seen increased, the likelihood of sampling decreased. Could a “wait and see” approach be costing dogs valuable treatment time and compromising ...

State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China CAS Key Laboratory of Chemistry of Northwestern Plant ...

Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Cancer Treated With ...